Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jul 23, 2025 · CIK: 1129928
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-report
Related Tickers: ONC
TL;DR
ONCOLYTICS BIOTECH (ONC) filed a 6-K, standard foreign issuer report.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on July 23, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Pharmaceutical Preparations industry. This filing is standard for companies that are not U.S. domestic issuers and are required to submit certain information to the SEC.
Why It Matters
This filing indicates that Oncolytics Biotech Inc. is meeting its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — A Form 6-K is a routine filing for foreign private issuers and does not typically contain material non-public information that would significantly alter risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- Calgary, Alberta, Canada (location) — Company Headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to submit certain information to the SEC.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of date July 23, 2025.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
What industry does Oncolytics Biotech Inc. belong to?
Oncolytics Biotech Inc. belongs to the Pharmaceutical Preparations industry, classified under SIC code 2834.
Does Oncolytics Biotech Inc. file an annual report on Form 20-F or 40-F?
The filing indicates that Oncolytics Biotech Inc. files an annual report on Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 23, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).